What is the Gold Standard?

The CEO Cancer Gold Standard™ is a series of cancer-related recommendations, developed by the CEO Roundtable on Cancer, to fight cancer in workplaces in the United States.  The Gold Standard is a comprehensive program with three main goals:

  • Risk Reduction through Lifestyle Change: reducing the risk of cancer by not using tobacco and by maintaining a healthy diet and active lifestyle,
  • Early Detection: detecting cancer at the earliest possible stage, when treatment has the best chance of improving outcomes, through age and gender-appropriate screenings, and
  • Quality Care: ensuring access to the best available cancer treatment.

The CEO Cancer Gold Standard ™ focuses on five critical areas, known as the Five Pillars.  The five pillars align with the Gold Standard’s goals as follows:

  • Risk Reduction through Lifestyle Change  
    • Tobacco Use
    • Diet & Nutrition
    • Physical Activity
  • Early Detection
    • Prevention, Screening and Early Detection 
  • Quality Care
    • Access to Quality Treatment and Clinical Trials

For each area of focus, or pillar, CEO Cancer Gold Standard organizations:

  • maintain a culture that encourages healthy lifestyles and provides the support needed when a diagnosis of cancer becomes a reality, and
  • offer benefits and programs that help to prevent cancer, detect it earlier and provide access to high-quality treatment, including cancer clinical trials.

 

GOLD STANDARD FOCUS

Read Dr. Leonard Berry’s powerful remarks to the CEO Roundtable on Cancer, September 11, 2009, Philadelphia, PA.
Employers of Choice Attacking Cancer



Learn how CEOs are making a difference in the lives of their employees by implementing the CEO Cancer Gold Standard.  Listen to what employees are saying about the Gold Standard in Their Own Voices.



Brochure.pngLearn much more about the Gold Standard by reading The Evidence and The Benefits to Your Organization

Did You Know?

Screening can prevent cancers of the cervix, colon, and rectum by allowing removal of precancerous tissue.